2021
Physician variation in the de‐adoption of ineffective statin and fibrate therapy
Everhart A, Desai NR, Dowd B, Herrin J, Higuera L, Jeffery MM, Jena AB, Ross JS, Shah ND, Smith LB, Karaca‐Mandic P. Physician variation in the de‐adoption of ineffective statin and fibrate therapy. Health Services Research 2021, 56: 919-931. PMID: 33569804, PMCID: PMC8522575, DOI: 10.1111/1475-6773.13630.Peer-Reviewed Original ResearchMeSH KeywordsAgedDiabetes Mellitus, Type 2Drug Therapy, CombinationDrug UtilizationFemaleFibric AcidsGuideline AdherenceHumansHydroxymethylglutaryl-CoA Reductase InhibitorsHypoglycemic AgentsHypolipidemic AgentsLongitudinal StudiesMaleMedicare Part CMiddle AgedPractice Guidelines as TopicPractice Patterns, Physicians'Risk FactorsUnited StatesConceptsMedicare Advantage patientsType 2 diabetic patientsACCORD lipid trialFibrate useAdvantage patientsCommercial patientsPhysician characteristicsLIPID trialFibrate therapyDiabetic patientsPhysician variationDiabetes careType 2 diabetes diagnosisContinuous insurance enrollmentPatient diabetes carePhysician random effectsGlucose-lowering drugsElectronic health record dataHealth record dataReal-world data assetConcurrent statinCardiovascular eventsStatin usersClinical evidenceManagement visits
2017
Hospital Readmissions among Commercially Insured and Medicare Advantage Beneficiaries with Diabetes and the Impact of Severe Hypoglycemic and Hyperglycemic Events
McCoy RG, Lipska KJ, Herrin J, Jeffery MM, Krumholz HM, Shah ND. Hospital Readmissions among Commercially Insured and Medicare Advantage Beneficiaries with Diabetes and the Impact of Severe Hypoglycemic and Hyperglycemic Events. Journal Of General Internal Medicine 2017, 32: 1097-1105. PMID: 28685482, PMCID: PMC5602759, DOI: 10.1007/s11606-017-4095-x.Peer-Reviewed Original ResearchConceptsDiabetes Complications Severity IndexSevere dysglycemiaIndex hospitalizationMedicare Advantage beneficiariesRisk factorsBetter care transitionsComplications Severity IndexPost-discharge managementIndependent risk factorYounger patient ageOptumLabs Data WarehouseStrong risk factorYears of ageBackgroundHospital readmissionsDesignRetrospective analysisCause readmissionUnplanned readmissionPatient agePrior hospitalizationReadmission ratesYounger patientsHeart failureHospital readmissionSevere hypoglycemiaDiabetes complications
2015
Long-term Outcomes After Stepping Down Asthma Controller Medications A Claims-Based, Time-to-Event Analysis
Rank MA, Johnson R, Branda M, Herrin J, van Houten H, Gionfriddo MR, Shah ND. Long-term Outcomes After Stepping Down Asthma Controller Medications A Claims-Based, Time-to-Event Analysis. CHEST Journal 2015, 148: 630-639. PMID: 25997080, PMCID: PMC4556120, DOI: 10.1378/chest.15-0301.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, InhalationAgedAged, 80 and overAnti-Asthmatic AgentsAsthmaComorbidityDrug Administration ScheduleEmergency Service, HospitalFemaleHospitalizationHumansInsurance Claim ReviewMaleMedicare Part CMedication AdherenceRecurrenceRetrospective StudiesRisk FactorsTreatment OutcomeUnited StatesConceptsAsthma controller medicationsAsthma exacerbationsLong-term outcomesController medicationsAsthma stabilityAsthma medicationsHealth-care provider guidanceFirst asthma exacerbationED visitsPrimary outcomeAdherence lapsesMedicationsExacerbationFour-month intervalsProvider guidanceStudy settingEvent analysisRetrospective timeMonthsAsthmaOutcomesIndividualsHospitalizationPeriodMonth stability